The board of directors of China Health Group Inc. announced the appointments with effect from April 15, 2016. Albert Qin has been appointed as the Chief Medical Officer of the Group. Dr. Qin served as Chief Scientific Officer and Corporate Officer, SymBio Pharmaceuticals in Tokyo, Japan from 2011 to 2015, concurrently holding Medical Director of R&D position (2010 to 2015). Mr. Liang Li has been appointed as the Financial Director of the Group. Mr. Li has over sixteen years of experience in finance management and auditing. From June 2008 to February 2016, Mr. Li served as Financial Controller in Jubilant Life Sciences (Shanghai) Co., Ltd, which is the subsidiary of Jubilant Life Science Inc. Ms. Jing Xu has been appointed as Company Secretary of the Company. Ms. Xu has over thirteen years of experience in finance management, tax
planning and management, investing and financing management, internal control and company secretary services.